Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP-LEUKEMIA: Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

NCT04741945 is registered in ClinicalTrials.gov with Kirsten Grønbæk as lead sponsor.

NCT NCT04741945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP-LEUKEMIA: Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS
Lead sponsor
Kirsten Grønbæk
Phase
Phase 2
Overall status
Recruiting
Start date
December 13, 2021
Completion date
February 28, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytopenia, myelodysplastic neoplasm, preleukemia, preleukemic anemia